Kaiser Health News
FDA Evaluates ‘Safety Concerns’ Over Dental Devices Featured in KHN-CBS Investigation
by Anna Werner, CBS News and Brett Kelman
Fri, 31 Mar 2023 15:00:00 +0000
In the wake of a KHN-CBS News investigation, the FDA on Thursday said it is “evaluating safety concerns” over the use of a dental appliance that multiple lawsuits allege caused grievous harm to patients.
The federal agency told the public in a “safety communication” posted on its website that it is looking not only at that product, the Anterior Growth Guidance Appliance, or AGGA, but other similar dental devices as well, including the Anterior Remodeling Appliance, or ARA, identified in a recent KHN and CBS News article.
The FDA said it is “aware of reports of serious complications with use of these devices” and asked that patients and health care providers report any complications experienced with them to the agency.
The agency said it is aware the devices have been used to treat conditions including sleep apnea and temporomandibular joint disorder of the jaw, also known as TMD or TMJ, but noted that “the safety and effectiveness of these devices intended for these uses have not been established.”
The AGGA device alone has been fitted on more than 10,000 dental patients, according to court records.
The KHN-CBS News investigation of the AGGA involved interviews with 11 patients who said they were hurt by the device — plus attorneys who said they represent or have represented at least 23 other patients — and dental specialists who said they’d examined patients who had experienced severe complications using the AGGA. The investigation found no record of the AGGA being registered with the FDA, despite the agency’s role in regulating medical and dental devices. The FDA confirmed Thursday that the devices “are not cleared or approved by the FDA.”
The AGGA’s inventor, Tennessee dentist Dr. Steve Galella, has said in a sworn court deposition that the AGGA was never submitted to the FDA, which he believes wouldn’t have jurisdiction over it.
At least 20 AGGA patients have in the past three years filed lawsuits against Galella and other defendants claiming the AGGA did not — and cannot — work. Plaintiffs allege that instead of expanding their jawbones, the AGGA left them with damaged gums, loose teeth, and eroded bone.
Additionally, KHN and CBS News reported that the Las Vegas Institute, a company that previously taught dentists to use the AGGA, now trains dentists to use another device its CEO has described as “almost exactly the same appliance.” That one is called the Anterior Remodeling Appliance, or ARA.
KHN and CBS News reached out Thursday to attorneys for Galella, the Las Vegas Institute, and the manufacturers of the AGGA and the ARA but received no immediate response.
Galella has declined to be interviewed by KHN and CBS News. His attorney, Alan Fumuso, previously said in a written statement that the AGGA “is safe and can achieve beneficial results.”
All the AGGA lawsuits are ongoing. Galella and the other defendants have denied liability in court filings. Cara Tenenbaum, a former senior policy adviser in the FDA’s device center, said reports of complications from these devices are of critical importance and can be submitted through FDA’s MedWatch portal.
“Whether that’s a dentist, an orthodontist, a surgeon, a patient, family member, or caregiver,” Tenenbaum said in a recent interview, “anyone can and should submit these reports so the FDA has a better understanding of what’s happening.”
In a court deposition, Galella said he personally used the AGGA on more than 600 patients and has for years trained other dentists how to use it. In video footage of one training session, produced in discovery in an AGGA lawsuit, Galella said the device puts pressure on a patient’s palate and causes an adult’s jaw to “remodel” forward, making them more attractive and “curing” common ailments, such as sleep apnea and TMJ.
“It’s OK to make a crapload of money,” Galella told dentists in the video. “You’re not ripping anybody off. You’re curing them. You’re helping them. You’re making their life totally beautiful forever and ever.”
In its Thursday announcement, the FDA said it is aware the devices have been used “to remodel the jaw in adults” but pointed out that devices like these called “fixed (non-removable) palatal expanders” are generally used on children and adolescents, “whose upper jaw bones are not yet fused.” By contrast, the FDA said, “an adult’s upper jaw bones are fused, and when a fixed palatal expansion device applies force, the palate is resistant to expansion. If forces are applied incorrectly to the teeth, serious complications can occur including chronic pain, tooth dislocation, flared teeth, uneven bite, difficulty eating, damaged gums, exposed roots, bone erosion, and tooth loss.”
Patients interviewed by KHN and CBS News described experiencing many of those problems. One patient who has sued, former professional clarinetist Boja Kragulj, said specialists later had to pull her four front teeth. She now wears false teeth.
Reached Thursday, Kragulj said: “While it’s too late for me and many others, there is some comfort in knowing the FDA is investigating the AGGA/ARA/ORA product and its claims. I hope other patients are spared the injuries and lost years that many of us have now suffered.”
The FDA said it plans “to investigate potential violations” in connection with the use of the devices, and that it is “identifying and contacting responsible entities to communicate [its] concerns.”
The American Dental Association, which has 159,000 dentist members, said it “will inform dentists of the FDA’s evaluation, and will continue to monitor for FDA updates regarding these devices and issues.”
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.
USE OUR CONTENT
This story can be republished for free (details).
By: Anna Werner, CBS News and Brett Kelman
Title: FDA Evaluates ‘Safety Concerns’ Over Dental Devices Featured in KHN-CBS Investigation
Sourced From: khn.org/news/article/fda-safety-concern-evaluation-agga-dental-device-investigation/
Published Date: Fri, 31 Mar 2023 15:00:00 +0000
Kaiser Health News
TV’s Dr. Oz Invested in Businesses Regulated by Agency Trump Wants Him To Lead
SUMMARY: President-elect Donald Trump nominated celebrity doctor Mehmet Oz to head the Centers for Medicare & Medicaid Services (CMS). Oz, known for his investments in healthcare, tech, and food companies, holds significant stakes in UnitedHealth Group, CVS Health, Amazon, and other companies involved in health insurance and pharmaceuticals, raising potential conflicts of interest. His financial ties include hospital stocks and pharmaceutical investments. Oz has expressed support for Medicare Advantage and criticized the food and healthcare industries. Critics question whether Oz can separate his financial interests from his role, particularly with companies doing business with the federal government.
The post TV’s Dr. Oz Invested in Businesses Regulated by Agency Trump Wants Him To Lead appeared first on kffhealthnews.org
Kaiser Health News
Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval
SUMMARY: Florida’s plan to import lower-cost prescription drugs from Canada, approved by the FDA nearly a year ago, has yet to launch. Governor Ron DeSantis praised the program, anticipated to save state agencies up to $180 million, but officials lack a start date. Despite bipartisan support for drug importation, complications persist, including operational challenges and safety concerns from the pharmaceutical industry. DeSantis has filed lawsuits against the FDA for delays and Florida has already spent $50 million on the initiative with no drugs imported. Other states, like Colorado, face similar hurdles in establishing importation programs.
The post Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval appeared first on kffhealthnews.org
Kaiser Health News
California Sets 15% Target for Primary Care Spending Over Next Decade
SUMMARY: California’s Office of Health Care Affordability has set a goal for insurers to allocate 15% of their spending to primary care by 2034, aiming to address the state’s shortage of primary care providers and improve preventive care. The current spending rate is 7%. This ambitious target seeks to reduce long-term healthcare costs by emphasizing early diagnosis and disease prevention. However, the state’s plan faces challenges, as it conflicts with a 3.5% cap on overall healthcare spending growth. The state will monitor progress, offering financial incentives to insurers who meet primary care spending goals, with the hope of expanding access and improving health outcomes.
The post California Sets 15% Target for Primary Care Spending Over Next Decade appeared first on kffhealthnews.org
-
Our Mississippi Home7 days ago
Create Art from Molten Metal: Southern Miss Sculpture to Host Annual Interactive Iron Pour
-
Local News6 days ago
Celebrate the holidays in Ocean Springs with free, festive activities for the family
-
News from the South - Georgia News Feed6 days ago
'Hunting for females' | First day of trial in Laken Riley murder reveals evidence not seen yet
-
News from the South - Alabama News Feed6 days ago
First woman installed as commanding officer of NAS Pensacola
-
Kaiser Health News3 days ago
A Closely Watched Trial Over Idaho’s Near-Total Abortion Ban Continues Tuesday
-
Mississippi Today6 days ago
On this day in 1972
-
News from the South - Alabama News Feed2 days ago
Trial underway for Sheila Agee, the mother accused in deadly Home Depot shooting
-
News from the South - Alabama News Feed2 days ago
Alabama's weather forecast is getting colder, and a widespread frost and freeze is likely by the …